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ABSTRACT
Objective: To compare the beneﬁts and harms of
a Dutch 10-session Community Occupational Therapy
programme for patients with Alzheimer’s disease with
the impact of a one session consultation at home in
German routine healthcare.
Design: A seven-centre, parallel group, active
controlled randomised controlled trial. Patients and
carers were not masked. Assessors were fully blind for
treatment allocation for one of two primary-outcome
measurements.
Setting: Patients’ homes.
Participants: Patients with mild to moderate
Alzheimer’s disease (Mini-Mental State Examination
14e24), living in the community with primary carer
available and without severe depression or behavioural
symptoms, were eligible.
Interventions: Experimental 10 home visits within
5 weeks by an occupational therapist, educating
patients in the performance of simpliﬁed daily activities
and in the use of aids to compensate for cognitive
decline; and educating carers in coping with behaviour
of the patient and in giving supervision to the patient.
Control one home visit including individual counselling
of patient and carer and explanation of a leaﬂet on
coping with dementia in daily life.
Outcome measures: The primary outcome was the
patient’s daily functioning measured with the Interview
of Deterioration in Daily activities in Dementia and the
Perceive, Recall, Plan and Perform System of Task
Analysis. Assessments were at baseline, 6, 16 and
26 weeks, with a postal assessment at 52 weeks.
Results: 141 patients were 1:1 randomised to the
experimental (N¼71) and control group (N¼70). Data
for 54 and 50 participants were analysed. Patients’
daily functioning did not differ signiﬁcantly between
the experimental and control group at week 6, 16, 26
or 52 and remained stable over 26 weeks in both
groups. No adverse events were associated with the
interventions.
Conclusions: In German healthcare, a Dutch 10-
session community occupational therapy was not
better than a one-session consultation for the daily
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Key messages
- A 10-session community occupational therapy
programme did not work more effectively than
a comprehensive one-session occupational
therapy consultation within German routine
healthcare.
Strengths and limitations of this study
- The main strength of this trial was an elaborate
multicentre RCT design within a routine care
setting using an active control group, a prolonged
follow-up and a strategy of video rating with fully
blind assessors. However, the patients and carer
could not be masked.
- The main limitation was that the training time for
the interventionists was shorter, and that they
had less treatment experience with the experi-
mental intervention than the therapists of the
Dutch original trial.
- Furthermore, we had to exclude 37 patients
(26%) from the multivariate analysis of variance
of the primary outcome because they withdrew;
or the assessment at one or more time points
was missing or not within the planned time
period. However, the attrition in both groups did
not demonstrate a systematic bias; the analysis
of the reduced patient sample with valid data did
not show a tendency to signiﬁcant group
differences; and an additional mixed model
analysis of all randomised patients did not
reveal any signiﬁcant differences. Consequently,
the hypothesis of better effects within the
experimental group must be rejected.
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Open Access Researchfunctioning of patients with Alzheimer’s disease. Further research on
the transfer of complex psychosocial is needed.
International Clinical Trials Registry Platform:
DRKS00000053; Funded by the German Federal Ministry of Health.
INTRODUCTION
Alzheimer’s disease causes high healthcare costs and
burdens patients and carers with severe problems in
Activities of Daily Living (ADL).
1 2 Consequently, the
improvement or the preservation of ADL is evaluated as
a patient-related outcome in clinical trials related to
dementia.
3 ADL, burden of care, ability to stay in the
community and quality-of-life issues are probably much
more relevant to patients and carers than the decelera-
tion of cognitive decline, another patient-related
outcome.
4 A synopsis of four systematic reviews analysing
73 RCTs on the efﬁcacy of pharmacological and
psychosocial interventions regarding everyday func-
tioning in dementia concluded that positive effects of
drugs on ADL are small (pooled effect sizes <0.28) and
heterogeneous regarding safety. In contrast to the well-
documented results for pharmacological interventions,
evidence for psychosocial interventions on ADL is
lacking.
5 However, a recent Dutch mono-centre RCT
demonstrated signiﬁcant positive effects of occupational
therapy on ADL (effect sizes of 2.4, p<0.0001).
6 There-
fore, the purpose of our multicentre RCT was to transfer
the Dutch community occupational therapy programme
in a broader context of German routine healthcare and
to evaluate its effectiveness and safety in comparison with
an active-control-group intervention.
Occupational therapy specialises in supporting inde-
pendence in ADL and is recommended in several
guidelines for dementia management.
7e9 Occupational
therapy uses a combined approach including activity
simpliﬁcation, environmental modiﬁcation, adaptive
aids, problem-solving strategies, skill training and carer
training.
71 01 1According to the bio-psycho-social health
model of the WHO, the negative impact of cognitive
deﬁcits on activities can be diminished by improving the
patient’s physical and social environment and by
tailoring the intervention to the patient’s capability.
12e15
Until July 2011, there was no systematic review on
community occupational therapy for people with
Alzheimer’s disease, but two research groups had
conducted RCTs in this subject. In the USA study,
occupational therapy demonstrated beneﬁcial effects on
patients’ challenging behaviours but not on ADL. No
information on adverse events was given.
14 16e18 In the
Netherlands, occupational therapy, tailored to the needs
of patients and carers, showed beneﬁts in the patient’s
ADL, mood, health status and quality of life and in the
carer’s sense of competence, mood, quality of life and
costs of informal care. No adverse events were reported
in either intervention or control group.
61 92 0
In the current randomised trial, we tested the
hypothesis that the Dutch 10-session Community Occu-
pational Therapy in Dementia Programme (COTiD)
would signiﬁcantly improve the daily functioning of
people with mild or moderate dementia, more so than
a one-session Community Occupational Therapy
Consultation (COTC). Secondary research questions
were whether these interventions would show any
difference in their effect on patient’s and primary carer’s
quality of life and mood; on the carer’s sense of
competence in the interaction with the patient; and on
long-term nursing-home placements.
METHODS
Design
In order to evaluate the superiority of COTiD, we used
a seven-centre single-blind, active-controlled design
with a 1:1 randomisation for two parallel groups. There
was no modiﬁcation in design or eligibility criteria from
the study protocol available at http://www.ncbi.nlm.
nih.gov/pmc/articles/PMC2761388/. The study was
registered at the German register of clinical trials,
which is connected to the International Clinical Trials
Registry Platform (http://apps.who.int/trialsearch/
¼>DRKS00000053).
Participants and setting
Patients were eligible to participate in the study if they
had mild to moderate dementia (Mini-Mental State
Examination (MMSE) 14e24) and were diagnosed as
having Alzheimer’s disease or mixed-type dementia,
according to Tenth Revision of the International Classi-
ﬁcation of Diseases criteria, by physicians with more than
5 years of experience in dementia diagnosis. Participants
had to live in the community either together with their
primary carer or with involvement of a carer providing
care at least twice a week. Patients with a score above 12
on the 30-items Geriatric Depression Scale or a major
need of physical nursing care of more than 120 min per
day (level 2 or higher according to the German Long-
Term Care Insurance Act) were excluded. Unstable
medical conditions or severe behavioural disturbances,
which did not allow participation in the study as judged
by the study physicians, were criteria for exclusion as well
as for discontinuation. Long-term nursing-home place-
ments of the patients during the treatment phase or
death of patient or primary carer were criteria for
discontinuation. The patient gave written informed
consent, and the carer consented by written format to
join and support the treatment procedures.
Patients were recruited from ﬁve outpatient memory
centres at university hospitals (in Bonn, Freiburg, Mainz,
Marburg and Tu ¨bingen); one municipal hospital in
Karlsruhe specialising in geriatric medicine; and one
neurological private practice in Berlin specialising in
neuropsychiatry and collaborating with an occupational
therapy private practice. The seven participating centres
are located throughout Germany in urban regions with
catchment areas of about 70000 to 700000 inhabitants.
They had all provided outpatient dementia care for
3e15 years. Their standard service comprised diagnostic
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recommendation of risk reduction, dementia medica-
tion and non-pharmacological treatments. Principal
investigators of the centres were psychiatrists, neurolo-
gists or geriatricians with 6e13 years of experience in
dementia care.
Interventions
The experimental intervention (COTiD) was designed
to improve the patient’s and the primary carer’s daily
functioning, and was based on an evidence-based treat-
ment manual.
6 19e23 COTiD consisted of 10 occupational
therapy sessions of 1 hour’s duration held over 5 weeks at
each patient’s home. In the diagnostic phase, comprising
three or four sessions, the occupational therapist
explored (1) the patient’s preferences and history of
daily activities; (2) their ability to perform activities and
to use compensatory strategies within the familiar envi-
ronment; (3) the possibilities of modifying the patient’s
home; (4) the carer’s activity preferences, problems in
care giving, coping strategies and abilities to supervise;
and (5) the interaction between carer and patient. In
a shared decision-making process during the goal setting
session, the patient and the carer selected the one or two
most meaningful activities out of a list of their prefer-
ences for daily activities to work on in occupational
therapy. During the treatment phase of ﬁve to six
sessions, the occupational therapist deﬁned, together
with the patient and the carer, more effective compen-
satory and environmental strategies to adapt both the
environment and the selected activities to the patient’s
habits and cognitive abilities. Patient and carer were
taught how to use these suggested adaptations within
strategies, activities and the environment in order to
improve their performance of daily activities. In addition,
the carer received practical and emotional support and
was coached in effective supervision, problem-solving and
coping strategies by means of cognitive-behavioural
interventions. Detailed description of the experimental
intervention has been published elsewhere.
23
For the German RCT, MG taught the content of the
translated treatment manual to 14 study-participant
occupational therapists in 16 h of seminars using
presentation, videos and role play with feedback and
group discussion. After the seminar and before the study
started, they needed to complete a full treatment series
for at least one pilot dyad of patient and carer. In the
study phase, the interventionists spent about 20 h per
patient for a full treatment series including 10 treatment
sessions, travel, reports and a multidisciplinary brieﬁng.
In Germany, a series of 10e30 sessions is within the
normal range of time that occupational therapists use
for the treatment of older outpatients diagnosed as
having other diseases, such as stroke or rheumatoid
arthritis.
The control group received 1 h of COTC at the
patient’s home conducted by the same study interven-
tionists. Based on material of the German Alzheimer’s
Society, two occupational therapists with more than
5 years of experience in dementia care had prepared
a leaﬂet of 10 pages.
24 25 The semistructured consulta-
tion was an explanation of 30 min of this leaﬂet and
a talk of 30 min on individual problems that arose from
the patient’s and carer’s needs. This included encour-
agement to stay active in everyday life, to maintain social
contacts and to use dementia services in the region for
which local addresses were listed in the leaﬂet. Occu-
pational therapists were taught the control intervention
within a 4 h seminar. Consultations of 30 min up to 1 h
duration about such issues are common in German
dementia care. A detailed description of the control
intervention as well as means of quality assurance in
experimental and control intervention has been
published elsewhere.
26
Outcome measures
The primary endpoint was the patients’ change in daily
functioning from baseline to follow-up time points at
week 6, 16 and 26 measured with the performance scale
of the Interview for Deterioration in Daily Living Activ-
ities in Dementia (IDDD).
27 This scale records the carer
rating of the patient’s need for assistance in the perfor-
mance of (1) washing oneself, (2) making tea or coffee,
(3) dressing, (4) combing one’s hair and brushing one’s
teeth, (5) eating, (6) using the toilet, (7) shopping, (8)
using the telephone, (9) preparing a meal, (10) cleaning
the house or doing minor repair work and (11) handling
ﬁnances. Each item is rated never¼0, seldom¼1, some-
times¼2, often¼3 or always¼4. The sum of scores
ranged from 0 to 44. Higher scores indicated a higher
need for assistance. Since the carer rating could not be
‘masked,’ daily functioning was additionally evaluated by
external raters fully ‘blind’ to the group assignment.
They rated videotapes of a challenging daily living task
and used the Perceive, Recall, Plan and Perform System
of Task Analysis (PRPP).
28 For the PRPP, raters had to
deﬁne single steps of the performed activity, and they
identiﬁed any activity step in which errors of accuracy,
omission, repetition or timing occurred. The number of
activity steps rated as incorrectly performed was divided
by the total number of activity steps, resulting in an
independence score indicated as a percentage (100%¼
all steps are error-free; table 1).
Secondary endpoints included mood, quality of life,
resource utilisation and possible harms (table 1). Asses-
sors ‘blind’ for the group assignment, completed
measurements at the patient’s home at baseline and at
weeks 6, 16 and 26, and arranged a postal survey of carer
questionnaires at week 52. The assessors had a minimum
of 1 year’s professional experience with older or cogni-
tively impaired people. They attended an introductory
seminar of 8 h. The complete assessment was applied
during a 2 h visit at each patient’s home including (1)
handing out and explaining the questionnaires to the
carer; (2) interviewing the patient (Dementia Quality of
Life Instrument and Short-Form 12 Health Survey
Questionnaire) in a separate room; (3) videotaping the
patient; and (4) receiving back the carer questionnaires,
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descriptions and means of quality management for
assessment as well as detailed scheme and psychometric
properties of all measurement instruments have been
reported recently.
26
All measurement instruments are validated and used
in dementia research.
29 30 For the present study, we
translated the IDDD into German according to high
methodological standards with two independent forward
and backward translations, analysis of discrepancies and
ﬁnal agreement by discussion with all translators. There
was no need to translate the PRPP because it was estab-
lished in The Netherlands and applied by Dutch raters.
There was one protocol amendment before recruitment
started. The Assessment of Motor and Process Skills was
replaced by the PRPP, because the Assessment of Motor
and Process Skills was not available in the German
language within the planned schedule.
Indicators of harm were deﬁned as patient or carer
death, number of patients with admission to hospital
and number of nights in hospital. These indicators were
recorded in interviews with the carer at intervals of
5e7 weeks over 52 weeks. Study sites had to report severe
adverse events to the study centre immediately when
each occurred. We did not assume a direct association
between the deﬁned harms and either the experimental
or the control intervention. However, increased daily
activities in the interventions group might have resulted
in a higher risk of falls or accidents and thus may indi-
rectly have led to more nights in hospital or, in the worst
case, to death.
Sample-size calculation
A sample size of 42 participants per group was calculated
to be necessary to detect an effect size of f¼0.10 on the
IDDD performance scale in an analysis of variance of two
groups and four time points, using a two-sided 5%
signiﬁcance level, a power of 80% and a correlation of
0.7 between the measurement time points.
31 According
to the Dutch original RCT, we expected a dropout rate of
10% at week 16, which was extrapolated to 40% at week
52. A 9-month inclusion period was anticipated as
necessary in order to recruit the 140 patients. Our
assumed effect size of f¼0.10 is based on a group-by-time
interaction and compatible with Cohen’s d¼0.20, which
corresponds to a small effect size, and any d over 0.8 is
large. Although the Dutch original RCT found effect
sizes of d¼2.4 in the IDDD performance scale at week
12, for this study the power was calculated much more
conservatively.
This was because we (1) introduced an active control
group, (2) investigated the programme effects under
varying care conditions in seven centres with interven-
tionists who were introduced in this new treatment and
were not as experienced as the Dutch study therapists
and (3) prolonged the follow-up period. Interim anal-
yses were not planned.
Randomisation and masking
The random allocation sequence was computer-gener-
ated with blocking by centre and groups of two persons,
without stratiﬁcation and in a ratio of 1:1 by a statistician
from a distant site. After enrolment, study site physicians
requested randomisation via email. The statistician
emailed the individual allocation to COTiD or COTC
exclusively to the site interventionist and stored the
allocation list at his distant site which was not available to
any study site staff. The interventionist scheduled treat-
ment sessions, faxed records to the distant coordinating
study centre and kept all documents strictly separated
from any other site staff. This was in order to avoid
contamination. Since the numbers of home visits
differed in the experimental and control groups,
masking of patients and carers was not possible.
However, study information did not include any prefer-
ence for a special treatment ‘arm.’ Patients and carers
were asked to give no information about their treatment
package to assessors or study physicians. All study
personnel were ‘blind’ for group assignment, except the
interventionists. Agreement between the assessors’ esti-
mation of group assignment and the actual group
assignment was 61%, and thus slightly over the expected
50% of agreement by chance. The procedure of external
video rating ensured the full ‘blinding’ of the external
raters for the PRPP primary outcome measure. Inde-
pendent research assistants cleaned the videotapes of
Table 1 Measurements of secondary endpoints
26
Endpoint Measurement
Patient’s initiative in daily activities Interview for Deterioration in Daily Living Activities in Dementia, initiative scale
Patient’s mood Cornell Scale for Depression in Dementia
Carer’s mood Center for Epidemiologic Depression Scale
Patient and carer’s quality of life Dementia Quality of Life Instrument, overall item
Short-Form 12 Health Survey Questionnaire physical
Short-Form 12 Health Survey Questionnaire mental
Carer’s interaction with patient Sense of Competence Questionnaire
Care by primary carer Resource Utilisation in Dementia, hours per day
Nursing home placement Resource Utilisation in Dementia, nights in nursing home (except respite care)
Harms No of adverse events
Resource Utilisation in Dementia, nights in hospital
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two Dutch raters not involved in the trial treatment. In
order to establish the inter-rater reliability, we tested 10
double ratings of the same video by the two raters and
found an intraclass correlation coefﬁcient of 0.9. Data
analysts were not ‘blind’ for the group assignment.
However, measurement time points and outcomes had
been published before data were available for analysis
26
and any decision to remove patients from the analyses is
reported in the present publication.
Statistical methods
Data were entered via special MS Access entry masks
automatically controlling for data plausibility. In addi-
tion, sections of entered data were checked for typing
errors by hand, in order to ensure an error rate lower
than 0.2%. The primary intention-to-treat analysis
included all allocated participants with valid data
whether they did or did not receive the complete inter-
vention. For the IDDD and the PRPP measurements of
the primary outcome, we performed a multivariate
analysis of variance (MANOVA) with repeated measures
with two groups and four measurement time points at
baseline, weeks 6, 16 and 26. A univariate ANOVA with
ﬁve measurement time points (+postal assessment in
week 52) was carried out for the secondary outcomes
and the IDDD. We did not adjust for baseline values,
because we found no marked group differences. In
order to deal with missing data occurring not in the
primary but in the secondary outcomes, we performed
secondary intention-to-treat analyses with multiple data
imputation using the Full Information Maximum Like-
lihood method.
32 We imputed data for all secondary
outcome measurements and all time points using SPSS
(V.19). In an additional analysis, we used the linear
mixed-effects models (MIXED) procedure in SPSS,
which allows an unequal number of repetitions and
a better handling of missing values.
All statistical tests were two-sided on an a level of 0.05.
Subgroup analyses were not planned.
RESULTS
Recruitment and participant ﬂow
We prolonged the planned recruitment period from
August 2008 to April 2009 by one additional month, up
to May 2009. This was in order to recruit the intended
sample size. The 52-week follow-up was closed in May
2010. One hundred and forty-one participants were
recruited (Berlin: 19; Bonn: 21; Freiburg: 26; Karls-
ruhe: 15; Mainz: 24; Marburg: 21; Tu ¨bingen: 15). The
ﬂow chart (ﬁgure 1) shows that attrition following
randomisation did not lead to any signiﬁcant group
differences.
Figure 1 Flow of participants
through the trial.
Assessed for eligibility (n=228)
Excluded (n=87)
Ineligible (n=47) 
Eligible but not recruited (n=40)
Allocated to occupational therapy (n=71) 
61  Received complete allocated intervention  
6  Allocated intervention was incomplete 
4  Did not receive allocated intervention (1 patient 
admitted to hospital; 2 withdrew without reason; 
1 withdrew as carer felt stressed)
Follow-up at 6 weeks (n=66) 
2  Lost for follow up 
3  Withdrew (1 no reason; 1 patient not 
convinced; 1 carer felt stressed) 
Allocation
and 
Intervention
Randomisation and baseline assessment (n = 141)
Follow-up at 16 weeks (n=59) 
2  Lost for follow up 
5  Withdrew (1 no reason; 1 patient not 
convinced; 3 carer felt stressed) 
Follow-up at 26 weeks (n=55) 
2  Lost for follow up 
1  Withdrew (patient ill) 
1 Carer  died 
Follow-up at 52 weeks (n=54) 
1  Lost for follow up
Allocated to control (n=70) 
66  Received complete allocated intervention  
4  Did not receive allocated intervention 
(withdrew: 1 no reason; 2 carer ill; 1 carer felt 
stressed)
Follow-up at 6 weeks (n=63) 
2 Lost  for  follow  up 
5  Withdrew (1 no reason; 1 patient ill; 1 carer felt 
stressed; 2 carer ill) 
Follow-up at 16 weeks (n=55) 
2 Lost  for  follow  up 
5  Withdrew (1 patient ill; 2 carer not convinced; 
2 carer felt stressed) 
1  Patient admitted to nursing home 
Follow-up at 26 weeks (n=50) 
3  Lost for follow up 
1 Withdrew  (1  patient  ill) 
1 Patient  died 
Follow-up at 52 weeks (n=50)
Follow up
Analysis
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Randomisation did avoid imbalances in baseline char-
acteristics (table 2) and pretreatment assessment data
(table 3) except in one item. Participants in the control
group had more moderate to severe limitations in their
ﬁnancial situation (14% vs 2%; p¼0.027). Because the
ﬁnancial situation is not known as a predictive factor
for functional decline, we did not adjust for this
imbalance.
33
Intervention delivery
Sixty-one of 71 (86%) allocated patientecarer dyads
received complete sessions in the COTiD group, 66 of 70
(94%) in the control group. In each group, four pairs
were lost before intervention. Six patientecarer dyads in
the COTiD had fewer than 10 sessions. Interventionists
rated the delivery of 20 predeﬁned treatment subpro-
cesses, ranging from interviewing patient and carer to
training of simpliﬁed activities or supporting the carer in
supervision. They scored treatment delivery as 78% in
the COTiD group and 80% in the control group. Inter-
ventionists rated the patient’s adherence in 67 cases of
the COTiD group, from 15 as hindering the delivery of
treatment; 26 as neutral and 26 as facilitating. Rating
criteria were the patient’s cooperation during interview,
goal setting and training; the daily changing mental
capacity; collaboration with the carer; and the accep-
tance of innovations. Ratings of carers’ adherence were:
5, hindering; 15, neutral; and 47, facilitating. The carer
adherence was assessed with regard to the cooperation
during scheduling, interview, goal setting and training to
supervise; the encouragement of the patient; the
acceptance of support service; and the implementation
of innovations. The adherence of the participants in the
control group could not be rated, because interven-
tionists had no further contact after the consultation.
Outcomes
The MANOVA in 104 completers (COTiD: n¼54;
control: n¼50) revealed no signiﬁcant groupetime
interaction effect in the primary outcome measurements
of patients’ daily functioning (ﬁgures 2, 3). Using the
arcsine transform
34 for the PRPR percentage did not
change results (original: p¼0.243; arcsine-transform:
p¼0.216). An additional mixed-models analysis of all
randomised patients (N¼141) as recommended by
Coley and colleagues
35 also revealed no signiﬁcant
interactions for the IDDD (p¼0.340) and the PRPP
(p¼0.785); details are provided as supplementary online
material. Tables 3, 4 show the mean, SD and group
difference including 95% CIs of an ANOVA for all
outcomes. Patients’ daily functioning did not change
signiﬁcantly over 26 weeks in either the experimental or
control group. In the postal 52-week follow-up, the
patients’ need for assistance increased in both groups,
and accordingly the carer’s hours of care for basic ADL
were higher. Two patients of the COTiD group were
placed in nursing homes 33 and 44 weeks after baseline
and one patient of the control group after 33 weeks.
To address the problem of missing data in single
measurement instruments, we performed a multiple
data imputation. We calculated a MANOVA over four
measurement time points for all primary and secondary
outcomes for all 104 completers. Ten different data
Table 2 Demographic and clinical characteristics
Community Occupational Therapy
in Dementia Programme Control
Analysed
(n[54)
Dropouts
(n[17)
Total
(n[71)
Analysed
(n[50)
Dropouts
(n[20)
Total
(n[70)
Age, years (SD) 78.0 (7.1) 77.2 (8.5) 77.8 (7.4) 78.7 (6.0) 78.3 (7.1) 78.5 (6.3)
Sex, female 29 (54%) 12 (71%) 41 (58%) 30 (60%) 10 (50%) 40 (57%)
Mini-Mental State Examination (SD) 20.4 (3.1) 19.0 (3.3) 20.2 (3.2) 20.7 (2.7) 20.3 (2.9) 20.7 (2.7)
Geriatric Depression Scale (SD) 6.9 (3.0) 5.6 (2.9) 6.5 (3.0) 5.2 (2.8) 6.1 (2.6) 5.5 (2.8)
Education
No school graduation 2 (4%) 1 (6%) 3 (4%) 1 (2%) 0 (0%) 1 (1%)
Middle school graduation (9 or 10 years) 41 (76%) 13 (76%) 54 (76%) 37 (74%) 15 (75%) 52 (74%)
High school graduation (12 or 13 years) 11 (20%) 3 (18%) 14 (20%) 12 (24%) 5 (25%) 17 (24%)
Financial situation as perceived by the carer
No limitation 40 (74%) 14 (82%) 54 (76%) 38 (76%) 13 (65%) 51 (73%)
Minor limitation 12 (22%) 1 (6%) 13 (18%) 3 (6%) 3 (15%) 6 (9%)
Moderate or severe limitation 1 (2%) 2 (12%) 3 (4%) 7 (14%) 4 (20%) 11 (16%)
No data 1 (2%) 0 (0.0%) 1 (1%) 2 (4%) 0 (0%) 2 (3%)
Primary carer
Age, years (SD) 65.4 (16.3) 63.1 (14.0) 64.9 (15.7) 65.9 (13.0) 61.4 (17.4) 64.5 (14.4)
Sex, female 38 (70%) 9 (53%) 47 (66%) 35 (70%) 18 (90%) 53 (76%)
Spouse 32 (59%) 8 (47%) 40 (56%) 31 (62%) 9 (45%) 40 (57%)
Daughter or son (in law) 20 (37%) 7 (41%) 27 (38%) 16 (32%) 9 (45%) 25 (36%)
Others 2 (4%) 2 (12%) 4 (6%) 3 (6%) 2 (10%) 5 (7%)
Living together (%) 41 (76%) 11 (65%) 52 (73%) 33 (66%) 14 (70%) 47 (67%)
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Community occupational therapy in Alzheimer’s diseaseimputations did not reveal any signiﬁcant timeegroup
interaction effects.
We also tested for study site differences at baseline and
found no signiﬁcant differences in a MANOVA with the
factors study sites and intervention groups (F (66, 432)¼
1.079, p¼0.323). Furthermore, no study-site effect was
found in the primary outcome analysing IDDD
and PRPP data of baseline, and weeks 6, 16 and 26
(IDDD: F (6, 90)¼0.724, p¼0.631; PRPP: F (6, 90)¼
1.758, p¼0.117).
Harms
There were no differences between intervention and
control group, either in the number of adverse events or
in their severity. The study-site physicians judged all
adverse events as unrelated to trial treatment or assess-
ment contacts. In the total sample of all randomised
participants (n¼141), two deaths of patients (both in the
control group) and one death of a carer (in the COTiD
group) were reported. In the COTiD group, 14 patients
were admitted to hospital for an average of 15 nights,
and 10 patients in the control group for an average of
18 nights. There was no difference between the two
groups in average number of nights admitted to hospital
(F (1, 97)¼2.785, p¼0.1). All events were unrelated to
the occupational therapy sessions.
DISCUSSION
In the results of this study, a 10-session community
occupational therapy in dementia programme (COTiD)
was found to be no more beneﬁcial than a one-session
consultation concerning short- and middle-term effects
on patients’ daily functioning. In both groups, the need
for assistance in basic and instrumental ADL and the
performance of a self-chosen daily living task remained
stable up to 6 months after baseline. No signiﬁcant
group differences could be found on secondary
outcomes, which were quality of life and mood of patient
and primary carer; patient’s initiative in daily activities;
carer’s sense of competence in interaction with the
patient; carer’s hours of daily care; and patient’s nursing
home placement. There were no adverse events associ-
ated with experimental or control intervention.
Limitations
Despite an elaborate study design, there are several limi-
tations in this study. We analysed only 104 completer dyads
from 141 recruited pairs (74%). However, (1) baseline
data of completers and non-completers did not show an
imbalance; (2) dyads were maintained, whose data were
valid, and for whom treatment was intended but not
received in the complete ITT-analysis; (3) an additional
mixed model analysis of all randomised patients also did
not reveal any signiﬁcant differences; and (4) the analysis
of the reduced patient sample with valid data did not show
even a tendency towards signiﬁcant group differences.
Thus, the hypothesis of group differences must be
rejected, because the analysis of completers usually favours
results in the direction of group differences.
A second shortcoming was that following the common
introductory seminar, the start of the study differed among
the sites due to different time lines in administrative
matters and approval of the local ethic commissions.
Therefore, a common repetition seminar for the inter-
ventionists could not be arranged after the pilot training.
This may have led to some heterogeneity in the interven-
tion, especially because in Germany, 11 newly introduced
interventionists performed the treatment compared with
two experienced experts in the original Dutch trial. We
addressed this problem with feedback on videos of treat-
ment sessions the interventionists sent in. Furthermore, we
arranged telephone supervision on demand.
We consider the contamination of the control inter-
vention with knowledge from the experimental interven-
tion to be low, because any speciﬁc intervention such as
activity selection, simpliﬁcation or training was precluded
by the limited time to carry out the control intervention.
Comparison
The Dutch RCT on the COTiD with waiting-control-
group design showed large effect sizes in the IDDD
performance scale at 6 and 12 weeks after baseline
Figure 2 Activities of Daily Living task performance of
Alzheimer’s patients following intense occupational therapy
compared with a single session control intervention; means
and 95% CIs of the Perceive, Recall, Plan and Perform System
of Task Analysis independence scale (N¼104 completers;
range: 100¼no errors to 0¼all errors). COTiD, Community
Occupational Therapy in Dementia Programme.
Figure 3 Need for assistance in Activities of Daily Living of
Alzheimer’s patients following intense occupational therapy
compared with a single-session control intervention; means
and 95% CIs of the Interview for Deterioration in Daily Living
Activities in Dementia performance scale (N¼104 completers;
range: 0¼never needed assistance to 44¼always needed
assistance). COTiD, Community Occupational Therapy in
Dementia Programme.
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Community occupational therapy in Alzheimer’s disease(d¼2.3 and 2.4, respectively).
6 Since the Dutch COTiD
programme demonstrated such highly positive effects,
we judged it as appropriate to conduct not an identical
replication, but a twofold transfer from the source to the
target country and from a mono-centre RCT design with
high expertise of interventionists to a pragmatic multi-
centre RCT design in routine care.
36 The Dutch and the
German sample did not differ remarkably in cognition at
baseline (MMSE: 19 vs 20), but did differ in the need for
assistance (IDDD performance: 24 vs 15). The German
patients showed a low need for assistance at the begin-
ning of the study. This was comparable with the IDDD
values of the Dutch patients at the end of the treatment.
This may have caused a ﬂoor effect on the IDDD.
Another mono-centre RCT in the USA compared
community occupational therapy and a less intensive
telephone consultation in patients with probable
dementia (MMSE: 13).
37 The authors found a small
effect size in daily functioning (d¼0.21). The initial
need of assistance in both studies was higher than in the
German sample. A systematic review of community
programmes in dementia
38 reported one study on
exercise and behavioural management with beneﬁcial
effects on daily functioning of patients with moderate
dementia (MMSE: 17); one trial on occupational therapy
with heterogeneous effects; and two studies on occupa-
tional therapy and music therapy with no signiﬁcant
effects. A current German health-technology assessment
on non-drug therapies in Alzheimer’s disease did not
identify any further community occupational therapy
trials.
39 The comparison of community intervention
trials reveals that study samples with a lower MMSE and
a higher need for assistance have a greater beneﬁt than
those with higher initial cognitive and daily functioning.
Similarly, a standardised synopsis of ADL outcomes in
pharmacological dementia trials indicated that samples
with an MMSE between 17 and 10 have the greatest
beneﬁt in ADL, while samples with higher MMSE scores
showed smaller effects.
40 However, different baseline
scores of cognitive and daily functioning alone cannot
explain the major difference between the ﬁndings in this
German study and the positive results of the Dutch RCT.
Detailed process evaluation and exploratory analyses of
the study data might show whether variations in study-
site context and treatment performance inﬂuenced the
intervention’s effectiveness.
Clinical and research implications
Published evidence for the effectiveness of community
occupational therapy in dementia is heterogeneous, as
indicated by a Dutch trial with large positive effects on
daily functioning, a few USA trials with no or small
positive effects on ADL and this German study showing
that 10 sessions were not better than one consultation. A
preventive one-session consultation might be hypoth-
esised as beneﬁcial for people with mild dementia and
an improved 10-session programme more speciﬁcally
adapted to the German healthcare system as beneﬁcial
for dementia patients with a moderate need for assis-
tance in ADL, as shown in the Dutch study in which most
people with dementia had a moderate to high need for
assistance at baseline.
Although we had expected smaller effect sizes than in
the Dutch original trial due to a changed study design
with (1) the introduction of an active control group, (2)
a variance in treatment performance in several centres,
(3) a prolonged follow-up time and (4) rigorous reduc-
tion in the analysed sample to participants with valid
data, it remains surprising that no signiﬁcant group
difference could be found in any of the primary or
secondary outcomes.
This study has shown that careful cross-national
comparisons are greatly needed, especially in complex
interventions, before they can be considered evidence-
based and implemented effectively in other healthcare
systems. Therefore, further analyses must investigate the
role of interventionists’ expertise and treatment perfor-
mance, and the role of participants’ needs and utilisa-
tion of healthcare resources, before conclusions on
international implementation of this intense occupa-
tional therapy intervention can be drawn.
Author afﬁliations
1Department of Occupational Therapy, Centre of Geriatric Medicine and
Gerontology Freiburg, University Hospital Freiburg, Freiburg, Germany
2Alzheimer Centre Nijmegen, Scientiﬁc Institute for Quality in Health Care and
Department of RehabilitationeOccupational Therapy, Radboud University
Nijmegen Medical Centre, Nijmegen, The Netherlands
3Department of Social Psychology and Methodology, University of Freiburg,
Freiburg, Germany
4Department of Psychiatry and Psychotherapy, University of Bonn, Bonn,
Germany
5Private Practice for Neurology, Psychiatry and Psychotherapy, Berlin,
Germany
6Centre of Geriatric Medicine and Geriatric Clinic at Diakonissenkrankenhaus
Karlsruhe-Ru ¨ppurr, Karlsruhe, Germany
7Department of Psychiatry and Psychotherapy, University Medical Center
Mainz, Mainz, Germany
8Department of Neurology, Philipps-University Marburg, Marburg, Germany
9Department of Psychiatry and Psychotherapy, Eberhard-Karls University
Tuebingen, Tu ¨bingen, Germany
10Alzheimer Centre Nijmegen, Scientiﬁc Institute for Quality in Health Care,
Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
11Department of Geriatrics, Alzheimer Centre Nijmegen, Radboud University
Nijmegen Medical Centre, Nijmegen, The Netherlands
12Section of Gerontopsychiatry and Neuropsychology, Centre of Geriatric
Medicine and Gerontology Freiburg, University Hospital Freiburg, Freiburg,
Germany
Acknowledgements We thank all participants and interventionists for their
contribution. We acknowledge C Mayers, Research Fellow, Faculty of Health
& Life Sciences, York St John University, UK, for critical reading and English
correction.
Funding German Federal Ministry of Health, Reference Number:
IIA5-2508FSB111/44-004.
Competing interests FJ: membership in DSMB of AC-immune; payment for
lectures from Pﬁzer, Esai and Novartis. BM: payment for lectures from various
pharmaceutical companies. RD: consultancy, grants, payment for lectures,
patents and meeting expenses from various pharmaceutical companies;
royalties and patents from University of Marburg. GE: grants from AC-immune
and Janssen-AL. MOR: consultancy for Jansen-Cilag and Numico. MH: grants
from Wyeth, Pﬁzer and Medivation; payment for lectures from Wyeth, Pﬁzer
and Merz.
10 Voigt-Radloff S, Graff M, Leonhart R, et al. BMJ Open 2011;1:e000096. doi:10.1136/bmjopen-2011-000096
Community occupational therapy in Alzheimer’s diseaseEthics approval Ethics approval was provided by the Medical Ethics
Committee of the University Hospital Freiburg (no 110/08).
Contributors SVR, MG, RL, GE and MH contributed to the study conception
and design. FJ, JB, BM, AF, RD, GE and MH acquired the data. SVR and KS
participated in data and study management, and prepared the statistical
analysis. RL performed the statistical analysis. SVR drafted the manuscript.
RL, MG, FJ, JB, BM, AF, RD, GE, MOR, MVD and MH revised the manuscript
critically for important intellectual content. All authors read and approved the
ﬁnal manuscript.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement Complete data sets can be provided on request for
fellow researchers in the context of collaborative projects and publications.
REFERENCES
1. Wancata J, Musalek M, Alexandrowicz R, et al. Number of dementia
sufferers in Europe between the years 2000 and 2050. Eur Psychiatry
2003;18:306e13.
2. Wimo A, Jonsson L, Winblad B. An estimate of the worldwide
prevalence and direct costs of dementia in 2003. Dement Geriatr
Cogn Disord 2006;21:175e81.
3. European Medicines Agency. Guideline on Medicinal Products for the
Treatment of Alzheimer’s Disease and other Dementias [Internet].
London, 2008. Doc. Ref. CPMP/EWP/553/95 Rev. 1. http://www.
emea.europa.eu/pdfs/human/ewp/055395en.pdf (accessed 29 Jul
2011).
4. Georges J, Jansen S, Jackson J, et al. Alzheimer’s disease in real
lifedthe dementia carer’s survey. Int J Geriatr Psychiatry
2008;23:546e51.
5. Voigt-Radloff S, Hu ¨ll M. Daily functioning in dementia:
pharmacological and non-pharmacological interventions demonstrate
small effects on heterogeneous scales: a synopsis of four health
technology assessments of the German Institute for Quality and
Efﬁciency in Health Care regarding the endpoint activities of daily
living. Psychiatr Prax 2011;38:221e31 (In German).
6. Graff MJ, Vernooij-Dassen MJ, Thijssen M, et al. Community based
occupational therapy for patients with dementia and their care givers:
randomised controlled trial. BMJ 2006;333:1196.
7. National Collaborating Centre for Mental Health (commissioned by
the Social Care Institute for Excellence and the National Institute for
Health and Clinical Excellence). Dementia. A NICE-SCIE Guideline
on Supporting People with Dementia and their Carers in Health and
Social Care. National Clinical Practice Guideline, Number 42. London:
The British Psychological Society and Gaskell, 2007.
8. German Society for Psychiatry, Psychotherapy and Neurology and
German Society for Neurology. Consented Guideline ‘Dementia’
[Internet], 2009. http://media.dgppn.de/mediadb/media/dgppn/pdf/
leitlinien/s3-leitlinie-demenz-lf.pdf (accessed 29 Jul 2011).
9. Work Group on Alzheimer’s Disease and other dementias. Practice
Guideline for the Treatment of Patients With Alzheimer’s Disease and
Other Dementias [Internet], 2007. http://www.psychiatryonline.com/
pracGuide/PracticePDFs/AlzPG101007.pdf (accessed 26 Oct 2010).
10. Steultjens EM, Dekker J, Bouter LM, et al. Evidence of the efﬁcacy of
occupational therapy in different conditions: an overview of
systematic reviews. Clin Rehabil 2005;19:247e54.
11. Voigt-Radloff S. Occuaptional therapy in dementia. In: Haberstroh J,
Pantel J, eds. Psychosocial Treatment in Dementia. German: AKA
Verlag Heidelberg, 2011.
12. World Health Organization. International Classiﬁcation of
Functioning, Disability and Health (ICF) [Internet]. Geneva, 2001.
http://www3.who.int/icf/icftem (accessed 29 Jul 2011).
13. Giovannetti T, Bettcher BM, Libon DJ, et al. Environmental
adaptations improve everyday action performance in Alzheimer’s
disease: empirical support from performance-based assessment.
Neuropsychology 2007;21:448e57.
14. Gitlin LN, Winter L, Burke J, et al. Tailored activities to manage
neuropsychiatric behaviors in persons with dementia and reduce
caregiver burden: a randomized pilot study. Am J Geriatr Psychiatry
2008;16:229e39.
15. Mittelman MS, Haley WE, Clay OJ, et al. Improving caregiver well-
being delays nursing home placement of patients with Alzheimer
disease. Neurology 2006;67:1592e9.
16. Gitlin LN, Corcoran M, Winter L, et al. A randomized, controlled trial of
a home environmental intervention: effect on efﬁcacy and upset in
caregivers and on daily function of persons with dementia.
Gerontologist 2001;41:4e14.
17. Gitlin LN, Hauck WW, Dennis MP, et al. Maintenance of effects of the
home environmental skill-building program for family caregivers and
individuals with Alzheimer’s disease and related disorders. J Gerontol
A Biol Sci Med Sci 2005;60:368e74.
18. Gitlin LN, Winter L, Vause Earland T, et al. The Tailored Activity
Program to reduce behavioral symptoms in individuals with dementia:
feasibility, acceptability, and replication potential. Gerontologist
2009;49:428e39.
19. Graff MJ, Vernooij-Dassen MJ, Thijssen M, et al. Effects of
community occupational therapy on quality of life, mood, and
health status in dementia patients and their caregivers: a
randomized controlled trial. J Gerontol A Biol Sci Med Sci
2007;62:1002e9.
20. Graff MJ, Adang EM, Vernooij-Dassen MJ, et al. Community
occupational therapy for older patients with dementia and their care
givers: cost effectiveness study. BMJ 2008;336:134e8.
21. Graff MJ, Melick van MB. The development, testing and
implementation of an occupational therapy guideline. The guideline
for the OT diagnosis and treatment of older persons with cognitive
impairments. Nederlands Tijdschrift voor Ergotherapie
2000;28:169e74 (in Dutch).
22. Graff MJ, Vernooij-Dassen MJ, Hoefnagels WH, et al. Occupational
therapy at home for older individuals with mild to moderate cognitive
impairments and their primary caregivers: a pilot study. OTJR:
Occupation, Participation and Health 2003;23:155e63.
23. Graff MJ, Vernooij-Dassen MJ, Zajec J, et al. How can occupational
therapy improve the daily performance and communication of an
older patient with dementia and his primary caregiver? A case study.
Dementia 2006;5:503e32.
24. German Alzheimer Society. Berlin: Leben mit Demenzkranken, 2003
(in German).
25. German Alzheimer Society. Berlin: Ratgeber Ha ¨usliche Versorgung
Demenzkranker, 2006 (in German).
26. Voigt-Radloff S, Graff M, Leonhart R, et al. WHEDA study:
effectiveness of occupational therapy at home for older people with
dementia and their caregiversethe design of a pragmatic randomised
controlled trial evaluating a Dutch programme in seven German
centres. BMC Geriatr 2009;9:44.
27. Teunisse S, Derix MM. The interview for deterioration in daily living
activities in dementia: agreement between primary and secondary
caregivers. Int Psychogeriatr 1997;9(Suppl 1):155e62.
28. Chapparo C, Ranka J. The PRPP System of Task Analysis: User’s
Training Manual. Research Edition. Sydney: OP Network, 2006.
29. Moniz-Cook E, Vernooij-Dassen M, Woods R, et al; INTERDEM
group. A European consensus on outcome measures for
psychosocial intervention research in dementia care. Aging Ment
Health 2008;12:14e29.
30. Wolfson C, Moride Y, Perrault A, et al. Drug Treatments for
Alzheimer’s Disease. II. A Review of Outcome Measures in Clinical
Trials. Ottawa: Canadian Coordinating Ofﬁce for Health Technology
Assessment (CCOHTA), 2000.
31. Faul F, Erdfelder E, Lang AG, et al. G*Power 3: A ﬂexible statistical
power analysis for the social, behavioral, and biomedical sciences.
Behav Res Methods 2007;39:175e91. G*POWER free software.
http://www.psycho.uni-duesseldorf.de/abteilungen/aap/gpower3/.
32. Allison P. Missing Data. Thousand Oaks, CA: Sage, 2002.
33. Plassman BL, Williams JW Jr, Burke JR, et al. Systematic review:
factors associated with risk for and possible prevention of cognitive
decline in later life. Ann Intern Med 2010;153:182e93.
34. Howell DC. Statistical Methods for Psychology. 4th edn. Belmont, CA:
Wadsworth, 1997.
35. Coley N, Gardette V, Cantet C, et al. How should we deal with
missing data in clinical trials involving Alzheimer’s disease patients?
Curr Alzheimer Res 2011;4:421e33.
36. Zwarenstein M, Treweek S, Gagnier JJ, et al; CONSORT group;
Pragmatic Trials in Healthcare (Practihc) group. Improving the
reporting of pragmatic trials: an extension of the CONSORT
statement. BMJ 2008;337:a2390.
37. Gitlin LN, Winter L, Dennis MP, et al. A biobehavioral home-based
intervention and the well-being of patients with dementia and
their caregivers: the COPE randomized trial. JAMA
2010;304:983e91.
38. Smits CH, de Lange J, Dro ¨es RM, et al. Effects of combined
intervention programmes for people with dementia living at home and
their caregivers: a systematic review. Int J Geriatr Psychiatry
2007;22:1181e93.
39. Rieckmann N, Schwarzbach C, Nocon M, et al. Concepts of care for
people with dementia. GMS Health Technol Assess 2009;5:Doc01.
http://www.egms.de/static/en/journals/hta/2009-5/hta000063.shtml
(accessed 29 Jul 2011) (in German).
40. Gauthier S, Lopez OL, Waldemar G, et al. Effects of donepezil on
activities of daily living: integrated analysis of patient data from
studies in mild, moderate and severe Alzheimer’s disease. Int
Psychogeriatr 2010;22:973e83.
PAGE fraction trail=11
Voigt-Radloff S, Graff M, Leonhart R, et al. BMJ Open 2011;1:e000096. doi:10.1136/bmjopen-2011-000096 11
Community occupational therapy in Alzheimer’s disease